Skip to the page

Data / Form D filings / StrataBio Inc.

StrataBio Inc.: Form D filing

StrataBio Inc., a biotechnology company in Tallahassee, FL, filed a Form D with the SEC in 2026. The latest, on August 31, 2026, reports $25,000 sold of a $500,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5583 Tower Woods Trl, Tallahassee, FL, 32303
Phone
(478) 461-5488
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Wyoming
Year incorporated
2026
Revenue range
No Revenues
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
2150600

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 31, 2026New notice$500,000$25,000$475,0001Aug 27, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sophia Tremari LombardoDirector, Promoter
Michael KramerExecutive Officer, Director, Promoter
Andrew Leon DeLuiseExecutive Officer, Director, Promoter
Robert French LongExecutive Officer, Director, Promoter
Corey ParkPromoter
Anthony FranklinExecutive Officer
Scott WardenExecutive Officer
Tom ChepucavageExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Aug 31, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what StrataBio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.